NCT06988696 The Effect of Perioperative Heated Sock Application on Hypothermia and Vital Signs in Bladder Tumor Surgery
| NCT ID | NCT06988696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | Bladder Tumor |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-11-01 with a primary completion date of 2025-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the effect of perioperative use of heated socks on the prevention of hypothermia and its impact on vital signs in patients undergoing bladder tumor surgery. It is anticipated that the data obtained from the study will provide evidence that the use of perioperative heated socks can help prevent hypothermia and positively influence vital signs in patients undergoing bladder tumor surgery.
Eligibility Criteria
Inclusion Criteria: * The duration of surgical intervention is between 2 and 4 hours, * Ability to read, write, understand and communicate in Turkish, * Voluntary participation in the study, * Does not require follow-up in intensive care before or after surgery, * Dementia, alzheimer etc. absence of disease affecting cognitive functions, * Absence of a disease that may affect thermoregulation due to systemic effects such as chronic obstructive pulmonary disease (COPD), cancer, intracranial benign/malignant tumor, epilepsy, multiple sclerosis, Parkinson's disease, and thyroid-related diseases, * Absence of drug use that may affect thermoregulation, * It is not uncomfortable to wear heat socks during application. Exclusion Criteria: * Mental retardation and the presence of any psychiatric disorder, * Being addicted to alcohol and drugs, * Dementia, alzheimer etc. have a disease that affects cognitive functions, * Having drug use that may affect thermoregulation, * Discomfort from wearing heat socks during application, * Having any disease that affects tissue perfusion, * Presence of any peripheral arterial and venous disease, * The need for intensive care before or after surgery
Contact & Investigator
SEVAL ULUBAY, PHD
PRINCIPAL INVESTIGATOR
Gazi State Hospital
Frequently Asked Questions
Who can join the NCT06988696 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Bladder Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06988696 currently recruiting?
Yes, NCT06988696 is actively recruiting participants. Contact the research team at sevalulubay@gmail.com for enrollment information.
Where is the NCT06988696 trial being conducted?
This trial is being conducted at Samsun, Turkey (Türkiye).
Who is sponsoring the NCT06988696 clinical trial?
NCT06988696 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is SEVAL ULUBAY, PHD at Gazi State Hospital. The trial plans to enroll 90 participants.